Waldencast plc (WALDW)
| Previous close | 0.1700 |
| Open | 0.9100 |
| Bid | 0.8501 x 1100 |
| Ask | 0.9195 x 1100 |
| Day's range | 0.2442 - 0.2442 |
| 52-week range | 0.2160 - 1.2400 |
| Volume | |
| Avg. volume | 2,679 |
| Market cap | N/A |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
GlobeNewswireWaldencast Announces Participation in Upcoming Investor Conferences
WHITE PLAINS, N.Y., May 30, 2024 (GLOBE NEWSWIRE) -- Waldencast plc (NASDAQ: WALD) (“Waldencast” or the “Company”), a global multi-brand beauty and wellness platform, today announced that the Company will participate in upcoming investor conferences. On June 5, 2024, the Company will participate in the TD Cowen 8th Annual Future of the Consumer Conference being held at the Conrad New York Downtown in New York City. Management will host a fireside chat presentation at 1:00 p.m. Eastern Time and h
- GlobeNewswire
Waldencast Reports Q1 2024 Financial Results
$68.3 million of Net Revenue+21.0% Comparable Net Revenue: +20.6% Obagi Skincare and +21.5% Milk MakeupAdjusted EBITDA of $11.4 million, up +12.9% vs Q1 2023 WHITE PLAINS, N.Y., May 21, 2024 (GLOBE NEWSWIRE) -- Waldencast plc (NASDAQ: WALD) (“Waldencast” or the “Company”), a global multi-brand beauty and wellness platform, today reported operating results for the quarter ended March 31, 2024 (“Q1 2024 Financials”) on Form 6-K to the U.S. Securities and Exchange Commission, which are also availab
- GlobeNewswire
Waldencast plc Announces First Quarter Fiscal 2024 Earnings Release Date, Conference Call and Webcast
NEW YORK, May 13, 2024 (GLOBE NEWSWIRE) -- Waldencast plc, (NASDAQ: WALD) (“Waldencast”), a global multi-brand beauty and wellness platform, announced that it will release its first quarter fiscal 2024 earnings results before the U.S. stock market opens on Tuesday, May 21, 2024. The Company will conduct a conference call to discuss its earnings results on the same day at 8:30am ET. Investors and analysts interested in participating in the conference call are invited to dial (877) 704-4453 or (20
